Alan Kohler, Eureka Report’s Editor-in-Chief, explores and explains the week’s news, views and events with smart people who like good coffee. Topics include but not limited to inflation, Bitcoin, Scott Morrison, vaccines and climate change. Got a question for next week's episode? Email themoneycafe@eurekareport.com.au.
…
continue reading
Sounds of Science is a monthly podcast about beginnings: how a molecule becomes a drug, how a rodent elucidates a disease pathway, how a horseshoe crab morphs into an infection fighter. The podcast is produced by Eureka, the scientific blog of Charles River, a contract research organization for drug discovery and development. Tune in and begin the journey.
…
continue reading
1
Superannuation, Housing Crisis, and the Kohler Curve Reset
41:14
41:14
Play later
Play later
Lists
Like
Liked
41:14
On the Money Café this week, Alan Kohler and Stephen Mayne discuss Nvidia's rise, shareholder activism at Lendlease, the government's hydrogen incentives, and the impact of superannuation access on housing. They also cover mining royalties, interest rates, inflation, and answer a number of questions on credit spreads, investment strategies, and muc…
…
continue reading
On the Money Café this week, Alan Kohler and James Thomson discuss the federal budget, the housing market, superannuation, BHP-Anglo, and answer a number of questions on tax, Perpetual, ETFs, and much more! See omnystudio.com/listener for privacy information.By Eureka Report
…
continue reading
On the Money Café this week, Alan Kohler and Stephen Mayne discuss the federal budget, rates, and answer a number of questions on productivity, superannuation, tax, and much more. See omnystudio.com/listener for privacy information.By Eureka Report
…
continue reading
On the Money Café this week, Alan Kohler and James Thomson discuss Qantas, the collapse of Bonza, interest rates, changes at Optus, bank results, and much more! See omnystudio.com/listener for privacy information.By Eureka Report
…
continue reading
1
Ep. 72: Artificial Intelligence in Cell and Gene Therapy
27:04
27:04
Play later
Play later
Lists
Like
Liked
27:04
Alex Sargent, Director of Process Development at Charles River in our Cell and Gene Therapy department, joins me to discuss the work he and his partner put into developing an algorithm to make his job faster and easier. How can you train a computer to accurately sift through the mountains of data generated in drug development? Listen now to find ou…
…
continue reading
On the Money Café this week, Alan Kohler and Stephen Mayne discuss BHP and Anglo American, inflation and interest rates, Elon Musk, and answer a number of questions on the housing market, ETFs, shareholder activism, and much more! See omnystudio.com/listener for privacy information.By Eureka Report
…
continue reading
On the Money Café this week, Alan Kohler and James Thomson look at the latest inquiry into Star Entertainment, forecast Richard Goyder’s future at Woodside, cast their eyes over the big banks, and answer a number of questions on the price of cocoa, the US presidential election, the housing market, and much more. See omnystudio.com/listener for priv…
…
continue reading
On the Money Café this week, Alan Kohler and Stephen Mayne discuss the tragic events that occurred in Sydney recently, look at the Seven Network and Bruce Lehrmann, put Star Entertainment under the microscope, look at the takeover blitz, and answer a number of questions on housing, super, the volatility index, and much more! See omnystudio.com/list…
…
continue reading
On the Money Café this week, Alan Kohler and James Thomson look at Craig Emerson's review of the supermarket landscape, Treasury Wine Estate's demerger plans, changes to the Qantas frequent flyer program, Woodside and Richard Goyder, and answer questions on housing, AI, and much more! See omnystudio.com/listener for privacy information.…
…
continue reading
On the Money Café this week, Alan Kohler and Stephen Mayne discuss Alan’s connection to the governor-general designate Samantha Mostyn, look at the Seven Network and Bruce Lehrmann, the latest takeover targets, AGM mini-season, and answer a number of questions on housing, the supermarkets, MMT, and much more! See omnystudio.com/listener for privacy…
…
continue reading
1
Ep. 71: Cellular Agriculture - Lab Grown Meat of the Future
31:28
31:28
Play later
Play later
Lists
Like
Liked
31:28
There have been many articles recently about cellular agriculture, or lab-grown meat products. But what happens when a company takes a practical approach to this science fiction concept? Joining me are Charles River's Steven Miklasz from our Biologics Testing Solutions team; and Ramsey Foty, Scientific Director for Fork & Good, a cultivated meat co…
…
continue reading
On the Money Café this week, Alan Kohler and James Thomson reflect on the quarter that was, modern monetary theory (MMT), the housing market, and answer a number of questions on mergers and acquisitions, payroll tax, the Australian dollar, and much more! See omnystudio.com/listener for privacy information.…
…
continue reading
On the Money Café this week, Alan Kohler and Stephen Mayne discuss Kevin Rudd and Donald Trump, executives being shown the door, TikTok, Rich Listers, the RBA and interest rates, and answer a number of questions on the pros and cons of different investment methods, financial markets and climate risk, the housing market and zoning, and much more. Se…
…
continue reading
On the Money Café this week, Alan Kohler and James Thomson look at the big four banks, economic long COVID, nuclear energy, and answer a number of questions on the market power of superannuation, CEO salaries, immigration, housing, and much more. See omnystudio.com/listener for privacy information.By Eureka Report
…
continue reading
On the Money Café this week, James Thomson and Stephen Mayne discuss International Women’s Day and the gender pay gap, the takeover binge, AGM season, and answer a number of questions on renewable energy, housing, and much more. See omnystudio.com/listener for privacy information.By Eureka Report
…
continue reading
1
Ep. 70: Benjamin Oakes and the Promise of CRISPR
28:49
28:49
Play later
Play later
Lists
Like
Liked
28:49
This month I am joined by Benjamin Oakes, scientist, entrepreneur, and co-founder of Scribe Therapeutics. He studied at UC Berkeley, working in the Doudna Lab and Savage Lab during the earliest days of CRISPR. We discuss his personal vision for the future of CRISPR, encouraging advances in the field, and the first ever drug approval for a CRISPR ba…
…
continue reading
On the Money Café this week, Alan Kohler and James Thomson share their thoughts on Australia's supermarket landscape, look at how Guzman y Gomez is tracking, the nation's ban on nuclear power, issue a capital gains tax correction, and answer a number of questions on housing, insurance companies, council rates, and much more. See omnystudio.com/list…
…
continue reading
On the Money Café this week, Alan Kohler and Stephen Mayne discuss takeovers, Woolworths, Qantas, corporate buybacks, and answer a number of questions on capital raisings, performance fees, private equity and much more. See omnystudio.com/listener for privacy information.By Eureka Report
…
continue reading
On the Money Café this week, Alan Kohler and James Thomson look at how results season is tracking, go through US inflation figures, what Bitcoin is up to, and answer a number of listener questions on the AI revolution, on-market buybacks, capital gains vs capital losses, the RBA and rates, and much more. See omnystudio.com/listener for privacy info…
…
continue reading
1
Corporate Profiteering and the RBA’s New Regime
37:57
37:57
Play later
Play later
Lists
Like
Liked
37:57
On the Money Café this week, Alan Kohler and Stephen Mayne discuss Allan Fels’ views on corporate profiteering, look at the RBA’s new regime, News Corp, and answer a number of questions on fossil fuels, AI, power prices, and much more! See omnystudio.com/listener for privacy information.By Eureka Report
…
continue reading
1
Ep. 69: Past and Future of Endotoxin Testing
35:49
35:49
Play later
Play later
Lists
Like
Liked
35:49
Norm Wainwright and Foster Jordan have been immersed in the field of limulus amebocyte lysate (LAL) testing for decades, and have seen the progress and refinement of this crucial safety test. With the 20th anniversary of Charles River's Endosafe Cartridge and the recent introduction of recombinant alternatives, we look back at the past and future o…
…
continue reading
On the Money Café this week, Alan Kohler and James Thomson discuss why Elon Musk is making headlines once more, look at the US Federal Reserve, dive into the world of AI and what impact it will have on civilisation, and answer a number of listener questions on the IPO market, Sigma and Chemist Warehouse, bracket creep, and much more. See omnystudio…
…
continue reading
1
Summer Reflections, Australia Day, and Tax Cuts
31:04
31:04
Play later
Play later
Lists
Like
Liked
31:04
The Money Café returns for 2024 with Stephen Mayne joining Alan Kohler to reflect on the summer past, discuss Australia Day, the stage 3 tax cuts, and go through a number of listener questions on the US election, flipping houses, and much more! See omnystudio.com/listener for privacy information.By Eureka Report
…
continue reading
I am joined by four experts in their field to discuss what will be hot in rare diseases, drug discovery, artificial intelligence, and animal models in 2024.By Charles River
…
continue reading
Alan Kohler is joined by James Thomson and Stephen Mayne for the final episode of The Money Café for 2023 to award the biggest winners and losers of the year, and what the big story in 2024 might be. Also: Chemist Warehouse, Woodside and Santos, a new migration strategy and much more. See omnystudio.com/listener for privacy information.…
…
continue reading
On the Money Café this week, Alan Kohler and James Thomson discuss Chemist Warehouse, GDP, interest rates, US markets, and answer a number of listener questions on superannuation, rental markets, fixed-rate mortgages, and much more! See omnystudio.com/listener for privacy information.By Eureka Report
…
continue reading
Molly Dupre, a lab assistant at Charles River's Reno site, was recently diagnosed with Niemann-Pick Type B/ Acid Sphingomyelinase Deficiency. After years of waiting, doctor's visits, and tests, she could finally put a name to the condition that flared up after the birth of her son. But what came next? She joins me to tell her story.…
…
continue reading
Buckle up for a ripper episode of The Money Café this week, with Alan Kohler discussing his Quarterly Essay on the state of Australia’s housing market, Stephen Mayne mulling over the busiest day of AGM season, plus lots of listener questions on superannuation, interest rates, tax, and much, much more! See omnystudio.com/listener for privacy informa…
…
continue reading
On the Money Café this week, Alan Kohler and James Thomson discuss the changes ahead for Optus and OpenAI, interest rates and inflation, and answer a number of listener questions on the collective power of superannuation funds, the housing market, and much more. See omnystudio.com/listener for privacy information.…
…
continue reading
On the Money Café this week, Alan Kohler and Stephen Mayne discuss Rupert Murdoch’s departure from News Corp, wages, state taxes, and answer a number of listener questions on AGMs, quantitative tightening, super savings, and much more. See omnystudio.com/listener for privacy information.By Eureka Report
…
continue reading
On the Money Café this week, Alan Kohler and James Thomson discuss the Optus outage and vulnerability of telecommunication networks, bank profit season, and answer several listener questions on interest rates, inflation, and the impact to the hip pocket. See omnystudio.com/listener for privacy information.…
…
continue reading
1
Ep. 66: When Drug Candidates Miss the Mark: Off-Target Liability
19:01
19:01
Play later
Play later
Lists
Like
Liked
19:01
Senior Principal Scientific Advisor Stan Spence joins me to discuss off-target liability: what happens when a drug misses its target? What are the risks to the patient if the off-target effects aren't caught early? Has there ever been an example of an off-target effect being beneficial to the patient? Find out here!…
…
continue reading
On the Money Café this week, Alan Kohler and Stephen Mayne discuss the latest bid for Origin Energy, climate change, Gina Rinehart, what to expect from tomorrow's Qantas AGM, and answer a number of listener questions on super wrap accounts, wars and inflation, interest rates, and much more. See omnystudio.com/listener for privacy information.…
…
continue reading
On the Money Café this week, Alan Kohler and James Thomson discuss the latest inflation figures and what it means for interest rates, the likelihood of a recession, Anthony Pratt, billionaires paying tax, what’s going on at Magellan, and much more. See omnystudio.com/listener for privacy information.…
…
continue reading
On the Money Café this week, Alan Kohler and Stephen Mayne discuss Stephen's board tilt for NAB, the latest AGM news, Ozempic, and answer a number of listener questions on short selling, housing, managed fund fees, and much more. See omnystudio.com/listener for privacy information.By Eureka Report
…
continue reading
On the Money Café this week, Alan Kohler and James Thomson discuss the changes afoot at Qantas, look at how the energy transition is tracking, the housing market, and answer a number of listener questions on the winners and losers of climate change, super wrap accounts, share dilution and much more. See omnystudio.com/listener for privacy informati…
…
continue reading
1
BONUS: Life After Cancer With Rachel and Susan
17:32
17:32
Play later
Play later
Lists
Like
Liked
17:32
Rachel Kiserow and Susan Desmond have joined us year after year as part of Eureka's Breast Cancer Roundtable. This year, they wanted to share what happens after - after the treatments, after remission - life after cancer.By Charles River
…
continue reading
On the Money Café this week, Alan Kohler and Stephen Mayne discuss the latest on the AGM front, look at what the RBA is up to, and answer a number of listener questions on investing in education over property, finding the best financial resources, the housing market, and much more. See omnystudio.com/listener for privacy information.…
…
continue reading
1
Ep. 65: The New England Compounding Center Tragedy
36:50
36:50
Play later
Play later
Lists
Like
Liked
36:50
For this episode, I am joined by Charles River's Doug Botkin and Pure Microbiology's Abby Roth to discuss the 2012 NECC meningitis outbreak. Doug and Abby bring their background in microbiology to explain how it happened, and how we can prevent such tragedies in the future.By Charles River
…
continue reading
On the Money Café this week, Alan Kohler and James Thomson discuss Richard Goyder’s future at Qantas, and the control both Qantas and Virgin have on the aviation market in Australia. They also examine the findings of Ziggy Switkowski’s PwC report, and answer a number of listener questions on term deposit rates, dot plots, and what world economics m…
…
continue reading
On the Money Café this week, Alan Kohler and Stephen Mayne discuss Josh Frydenberg’s new role at Goldman Sachs, the gap between housing construction and immigration, Qantas, the upcoming AGM season, and answer listener questions on private versus public companies, council rates, and much more. See omnystudio.com/listener for privacy information.…
…
continue reading
On the Money Café this week, Alan Kohler and James Thomson discuss the benefits of an Italian train network, look into the latest issues engulfing Qantas, check in on how the property sector is tracking, and answer a number of listener questions on the future of open plan offices, investing in the Mexican stock market, and much more. See omnystudio…
…
continue reading
Charles River experts Justin Bryans and Elizabeth Anderson join me for a spirited discussion of where we are now in oncology research. Could we ever see a world without cancer?By Charles River
…
continue reading
On the Money Café this week, Alan Kohler and James Thomson discuss Premier Investments and a mismatch between retailing personalities; wriggle room for cautious CEOs in earnings season; a declining birthrate in China and Australian companies; debt piles and 10-year bond rates; and the PM’s son and PwC making the front pages. Also: Wealth per capita…
…
continue reading
On the Money Café this week, Alan Kohler and Stephen Mayne whip through the Boomer apology getting millions of views online, the better side winning; Endeavour and pokies; the value of Chadstone; a year since the watershed $369 billion IRA law and counting; and Murdoch’s latest squeeze. Also: four or five big banks; unemployment and boomtime; measu…
…
continue reading
On the Money Café this week, Alan Kohler and James Thomson discuss working from home, valuations of office properties and debt covenants, CBA’s earnings, Optus and the women’s soccer goldmine and the Zimmermann success story. Also: vacant homes or just not at home; Tim’s too-long question on Airbnb; moving in with Mum and Dad and travelling oversea…
…
continue reading
On the Money Café this week, Alan Kohler and Stephen Mayne look at the outlook for rates, discuss the exclusive Qantas Chairman's Lounge, ponder whether Trump will become president again, and answer a number of listener questions on tax, Airbnb, and much more. See omnystudio.com/listener for privacy information.…
…
continue reading
1
Ep. 63: Gene Therapy Manufacturing: Two Perspectives
23:24
23:24
Play later
Play later
Lists
Like
Liked
23:24
Manufacturing gene therapies is a hot topic in the pharma field, on both the supplier and the client ends. Joining me to discuss this issue is Charles River Associate Director of Gene Therapy, Andrew Frazer, and Purespring Therapeutics' VP of Chemistry, Manufacturing and Controls, Amanda Weiss.By Charles River
…
continue reading
Alan, Stephen, James get together for a special, bumper edition of the Money Café this week to celebrate one million downloads! On the table at Le Clec: the railway barons of tech, rebranding Twitter, the growing list of billionaire divorces, Macquarie and the PwC connection, a guide to inflation and the chance of a rate hike. Also: how lucky is th…
…
continue reading
On the Money Café this week, Alan Kohler and James Thomson go through who's left on the RBA shortlist for governor after Luci Ellis jumped to Westpac, what zero inflation means for China and why AI robots should be green or red. Also: full takeovers, pumping more into super, surcharges on holiday homes, corporates paying pollies, mortgage rates in …
…
continue reading